Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
33.77
-0.74 (-2.14%)
After Hours: 33.78 +0.01 (0.02%)
Feb 8, 4:59PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 32.90 - 34.15
52 week 28.20 - 45.05
Open 33.77
Vol / Avg. 375,221.00/205,834.00
Mkt cap 710.81M
P/E 23.68
Div/yield     -
EPS 1.43
Shares 22.73M
Beta 1.78
Inst. own 98%
Feb 11, 2016
Cynosure Inc at Leerink Partners Global Healthcare Conference - 8:55AM EST - Add to calendar
Feb 9, 2016
Q4 2015 Cynosure Inc Earnings Release - 9:30AM EST - Add to calendar
Feb 9, 2016
Q4 2015 Cynosure Inc Earnings Call - 9:00AM EST - Add to calendar
Nov 17, 2015
Cynosure Inc at Stifel Healthcare Conference
Nov 16, 2015
Cynosure Inc at Brean Capital Life Sciences Summit Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 4.12% 10.72%
Operating margin 6.17% 7.27%
EBITD margin - 22.47%
Return on average assets 2.62% 7.18%
Return on average equity 3.35% 9.13%
Employees 755 -
CDP Score - -

Address

5 Carlisle Rd
WESTFORD, MA 01886-3601
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cynosure Inc. develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. The Company also markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies.

Officers and directors

Michael R. Davin Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy W. Baker President, Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas J. Delaney Executive Vice President - Worldwide Sales
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 71
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 56
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 49
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 56
Bio & Compensation  - Reuters